The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma is a research paper published in Developmental Cell (2022). On theSindex it has a DataRank of 1.7. It has been cited 73 times, with 68 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.646
From this paper's citation signal
Citation Network Contribution
1.1
From 51 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 68 citers.
Damon Runyon Cancer Research Foundation
Grant: DRSG-33P-20
National Cancer Institute
Grant: CA21765
National Cancer Institute
Grant: R01CA219686
National Cancer Institute
Grant: U01CA263969
NCI NIH HHS
Grant: P30 CA021765
NCI NIH HHS
Grant: R01 CA262790
American Lebanese Syrian Associated Charities
Hyundai Hope On Wheels
Alex's Lemonade Stand Foundation for Childhood Cancer
National Pediatric Cancer Foundation
Howard Hughes Medical Institute
National Institutes of Health
Howard Hughes Medical Institute
Fields of Study
MeSH Terms
Keywords